Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New drug shows promise for bulging eyes in thyroid disease

NCT ID NCT06126783

First seen May 05, 2026 · Last updated May 22, 2026 · Updated 4 times

Summary

This study looked at how well IBI311 works over a longer time for people with thyroid eye disease, a condition that can cause bulging eyes and discomfort. 91 adults who finished a previous study took part. The main goal was to see if the drug reduced eye bulging by at least 2 millimeters without making the other eye worse. The study also checked for side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE, TED are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, 200000, China

Conditions

Explore the condition pages connected to this study.